Lateral ventricle enlargement, which is definitely strongly associated with ARIA-causing MABs and is presumed to be mechanistically linked to ARIAs, has been proven for both lecanemab and donanemab (Alves et al
Lateral ventricle enlargement, which is definitely strongly associated with ARIA-causing MABs and is presumed to be mechanistically linked to ARIAs, […]